Technology News and Research

RSS

VeriChip to commence Phase II development of an in vivo glucose-sensing RFID microchip

VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.

1 Oct 2009

First prescription foam formulation of benzoyl peroxide available

Onset Therapeutics, a specialty pharmaceutical company focused on dermatology, announced today the commercial availability of BenzEFoam (benzoyl peroxide) 5.3% Emollient Foam, the first prescription foam formulation of benzoyl peroxide.

1 Oct 2009

NCI selects Integral Molecular to map epitopes for monoclonal antibodies

Integral Molecular, Inc. has been selected by the National Cancer Institute (NCI) to map epitopes for monoclonal antibodies directed against cancer biomarkers. Protein targets of interest to the Clinical Cancer Proteomics community will be analyzed using Shotgun Mutagenesis Mapping technology to identify amino acids that are essential for antibody binding, allowing the discovery and characterization of cancer-specific biomarkers.

1 Oct 2009

Talyst collaborates with healthcare consultancy to provide implementation services

Talyst, a leader in pharmacy automation systems, announced today a partnership with RXinnovate, a healthcare consultancy, to offer top-of-the-line implementation services to Talyst's clients in the acute care industry.

1 Oct 2009

CVRx commences enrollment in study evaluating the Rheos System to treat heart failure

CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).

1 Oct 2009

TriPollar technology effective in reducing stretch marks

Dr. Worophong Manuskiatti has been invited to present results of his study "Treatment of striae distensae in skin phototypes IV-V with a TriPollar radiofrequency device" in the upcoming meeting of the European Academy of Dermatology and Venereology (EADV) Conference held on October 7-10, 2009 in Berlin, Germany.

1 Oct 2009

Fovea Pharmaceuticals to sell 100% of its share to Sanofi-Aventis

Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis. Fovea has a portfolio of three clinical compounds, a unique technology platform and several discovery programs dedicated to back of the eye diseases.

1 Oct 2009

Presence of sequencing technologies in routine hospital and physician office labs over the next decade

As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.

1 Oct 2009

iTech Medical provides update on MPR system

iTech Medical, Inc. (OTC Bulletin Board: IMSU; FWB: 0IM), a medical information technology company, today provided an update on the Company's clinical and regulatory plans for its proprietary Muscle Pattern Recognition (MPR) System.

1 Oct 2009

Health information technology can improve health care for Americans living in rural communities

HHS Secretary Kathleen Sebelius today released a report on how health information technology can improve health care for Americans living in rural communities. The report examines how the Columbia Basin Health Association in Othello, Wash., uses health information technology to improve health care quality and patient safety as well as promote care coordination and continuity. The complete report is available now at www.healthreform.gov.

1 Oct 2009

Doris Duke Innovations award for sickle cell disease research

Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.

1 Oct 2009

Grand Opportunity grant to pursue "whole-genome" sequencing of patients with autism

Children's Hospital Boston, with the Broad Institute and Harvard Medical School, has been awarded a Grand Opportunity grant from the National Institute of Mental Health as part of the federal stimulus package, to pursue "whole-genome" sequencing of patients with autism, using new technologies for rapid DNA sequencing to better understand autism's causes.

1 Oct 2009

Astra Tech, Dental Wings announce strategic alliance

Astra Tech, a market leader in the field of implant dentistry, announces their strategic alliance with Dental Wings, the Canadian-based provider of CAD/CAM solutions with specialized development of 3D scanners, beginning in early 2010. As a result, Dental Wings users worldwide will have the ability to remotely transfer scans to Astra Tech’s design and manufacturing centers for the production of Atlantis™ patient-specific abutments for all major implant systems.

1 Oct 2009

Adimab announces the completion of Series D financing

Adimab, Inc., a world leader in human antibody discovery, today announced the closing of a Series D financing led by Google Ventures with participation by previous investors Polaris Ventures, SV Life Sciences, OrbiMed Advisors and Borealis Ventures. Bill Maris of Google Ventures will join Adimab's Board of Directors. The total amount of the financing was not disclosed.

1 Oct 2009

TMS closes final tranche of Series E Preferred Financing to a total of $6 million

TechniScan Medical Systems (TMS) Inc., a Salt Lake City-based developer of ultrasound technology for breast imaging, announced the close of the final tranche of their Series E Preferred Financing of $1.1 million, bringing the total raised in the Series E financing to just over $6 million.

1 Oct 2009

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.

1 Oct 2009

Watch4net installs its APG Software Suite at Clarian Health

Current economic conditions are affecting healthcare providers in terms of limited personnel and budget constraints," said Bob Swann, Executive Director, IT Operations, Clarian Health. An industry typically marked by growth is starting to feel the effects of the economic slowdown. Senior level executives are being tasked to run leaner organizations with fewer resources and still maintain a premier level of patient care.

1 Oct 2009

Revolutions Medical's new corporate headquarters in Charleston

Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has moved its expanded operations to new corporate headquarters in Charleston and is hosting a Grand Opening ceremony on October 8th, 2009 at 5:30pm - 7:30pm ET

1 Oct 2009

Daniel Callahan reveals how medical technology costs can destroy one's health care system

Your elderly father is ill. Would you be prepared to tell him that he will not be getting the necessary diagnostic tests because he is over the age of 65? TAMING THE BELOVED BEAST: How Medical Technology Costs are Destroying Our Health Care System (Cloth $29.95, 978-0-691-14236-4, September 30, 2009) is a provocative new take on the toughest issue President Obama has yet faced in office.

1 Oct 2009

Phase 1 clinical trial to test safety and activity of human MAB launched in India

MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.

1 Oct 2009

Technology News and Research

VeriChip to commence Phase II development of an in vivo glucose-sensing RFID microchip

First prescription foam formulation of benzoyl peroxide available

NCI selects Integral Molecular to map epitopes for monoclonal antibodies

Talyst collaborates with healthcare consultancy to provide implementation services

CVRx commences enrollment in study evaluating the Rheos System to treat heart failure

TriPollar technology effective in reducing stretch marks

Fovea Pharmaceuticals to sell 100% of its share to Sanofi-Aventis

Presence of sequencing technologies in routine hospital and physician office labs over the next decade

iTech Medical provides update on MPR system

Health information technology can improve health care for Americans living in rural communities

Doris Duke Innovations award for sickle cell disease research

Grand Opportunity grant to pursue "whole-genome" sequencing of patients with autism

Astra Tech, Dental Wings announce strategic alliance

Adimab announces the completion of Series D financing

TMS closes final tranche of Series E Preferred Financing to a total of $6 million

Raptor Pharmaceutical appoints Llew Keltner to its board of directors

Watch4net installs its APG Software Suite at Clarian Health

Revolutions Medical's new corporate headquarters in Charleston

Daniel Callahan reveals how medical technology costs can destroy one's health care system

Phase 1 clinical trial to test safety and activity of human MAB launched in India

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News